{"id":"a5d9a504-4bcb-438f-9166-798db8bcecb7","arxiv_id":"2607.11343","paper_version":1,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":5.5,"correctness_risk":"medium","formal_verification":"none","parameter_count":2,"one_line_summary":"A longitudinal multi-view network that jointly models aligned CC and MLO mammograms outperforms prior risk models on EMBED and CSAW-CC across density and cancer subgroups.","lead":"LMV-Net is a deep learning model that predicts breast cancer risk by jointly reading both standard mammogram angles over time with explicit alignment. If the gains hold, it could support more personalized screening intervals and earlier high-risk identification.","discovery_kind":"new_method","skeptic_critique":{"model":"grok-4.5","headline":"Abstract-only review: outperformance claim cannot be stress-tested; Reader's evaluation-protocol concern remains the load-bearing gap.","rationale":"The Reader correctly flags that an abstract-only empirical methods paper cannot support a high-confidence verdict on outperformance. I find no additional load-bearing technical flaw (no contradictory equations, no impossible claims, no circular reasoning) that would push the verdict toward REJECT. The contribution is a reasonable systems composition of two previously useful ingredients (multi-view + explicit longitudinal alignment). Because the full text is unavailable, the evaluation-protocol concern remains the single most important untested assumption, and the appropriate status stays UNVERDICTED with low confidence. No adjustment is warranted.","tokens_in":2015,"tokens_out":509,"duration_ms":4030,"concrete_test":"When the full paper (or the claimed GitHub release) is available: (1) confirm identical train/val/test patient-level splits, follow-up windows, and cancer-label definitions for LMV-Net and every reported baseline; (2) re-run the strongest baseline under the authors' exact preprocessing and hyperparameter budget; (3) check whether the multi-view + longitudinal ablations still show statistically significant gains (e.g., AUC/C-index with 95% CIs) after those controls. If the gap collapses under matched conditions, the outperformance claim weakens.","verdict_should_be":"UNCHANGED","load_bearing_attack":"No significant new objection beyond the Reader's. The central claim is empirical outperformance of LMV-Net (joint multi-view + explicit longitudinal alignment) over SOTA on EMBED and CSAW-CC, overall and in density/cancer subgroups. With only the abstract available, methods, architecture details, training protocol, metrics, ablations, confidence intervals, and baseline reimplementation conditions are all absent. The claim is therefore not verifiable from the provided material. Nothing in the abstract is internally inconsistent; the clinical motivation is coherent and code is claimed available. The single load-bearing premise remains exactly the one the Reader identified: that the reported gains are not artifacts of splits, follow-up windows, label definitions, preprocessing, or unequal hyperparameter budgets, and that prior single-view-aligned or multi-view-unaligned baselines were reimplemented under comparable conditions. That premise cannot be checked without the full paper.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.5","summary":"The manuscript proposes LMV-Net, a longitudinal multi-view deep learning model for breast cancer risk prediction from screening mammography. It jointly analyzes anatomically complementary CC and MLO views inside an explicitly aligned longitudinal framework, aiming to exploit complementary spatial-temporal information that prior work either models with single-view explicit alignment or multi-view without explicit longitudinal alignment. The abstract reports evaluation on the public EMBED and CSAW-CC datasets against state-of-the-art risk prediction methods, claiming consistent outperformance overall and across breast density and cancer subgroups, with code released at a public repository.","tokens_in":2215,"tokens_out":720,"duration_ms":11434,"significance":"If the empirical claims hold under rigorous, comparable evaluation, jointly modeling multi-view anatomy with explicit longitudinal alignment would be a useful incremental contribution to mammography-based risk prediction and could support more personalized screening intervals and earlier identification of high-risk patients. The clinical motivation is coherent, the use of two public datasets is appropriate, and the stated code release is a concrete reproducibility strength. Significance cannot be fully judged from the abstract alone, because quantitative effect sizes, subgroup robustness, and fairness of baseline comparisons are not yet inspectable.","major_comments":[{"comment":"The central claim of consistent outperformance over SOTA on EMBED and CSAW-CC (overall and in density/cancer subgroups) is not verifiable from the provided material: no metrics, confidence intervals, statistical tests, result tables, or ablation numbers appear in the abstract. For an empirical ML paper this is load-bearing; the claim cannot be accepted or rejected without those results.","section":null},{"comment":"The load-bearing premise that gains come from joint multi-view + explicit longitudinal alignment (rather than evaluation-protocol artifacts) cannot be checked. The abstract does not specify train/val/test splits, follow-up windows, label definitions, preprocessing, hyperparameter budgets, or whether prior single-view-aligned and multi-view-unaligned baselines were reimplemented under matched conditions. Without that protocol, the outperformance attribution remains unsubstantiated.","section":null},{"comment":"Architectural and training details of LMV-Net (how CC/MLO complementarity is fused, how explicit longitudinal alignment is realized jointly across views, loss design, and training protocol) are absent from the abstract. These are required to assess whether the method is a genuine technical contribution versus a re-packaging of existing components under a new name.","section":null}],"minor_comments":[{"comment":"The abstract is readable and clinically motivated, but it would benefit from at least one headline quantitative result (e.g., AUC or C-index with CI on each dataset) so readers can gauge effect size before the full paper.","section":null},{"comment":"Clarify in the abstract whether 'cancer subgroups' means cancer subtype, stage, or time-to-event strata, to avoid ambiguity for clinical readers.","section":null}],"recommendation":"uncertain","confidential_remarks":"Only the abstract was available for this review (full text not provided). I therefore cannot produce a standard accept/revise/reject decision on soundness. Recommendation is uncertain pending the full manuscript with methods, results tables, ablations, and baseline reimplementation details. If the full paper is supplied, the primary review focus should be evaluation protocol parity and quantitative subgroup results, not the clinical framing."},"author_rebuttal":null,"desk_editor":{"model":"grok-4.5","letter":"Colleague — only the abstract is in front of us, so this is a thin read. Punchline: LMV-Net is a systems composition that jointly does explicit longitudinal alignment and multi-view (CC+MLO) modeling for breast cancer risk. The authors say prior work did one or the other, not both. That gap is real enough on its face, and the clinical motivation (personalized intervals, better stratification) is clear and not oversold.\n\nWhat is new is the joint setup and the claim of consistent gains on two public datasets (EMBED, CSAW-CC), overall and in density/cancer subgroups, with code promised. That is a legitimate empirical contribution if the full paper backs it. Nothing in the abstract is incoherent; it is ordinary supervised risk prediction on external public data, not circular derivation.\n\nSoft spots are almost entirely about missing evidence, not about a broken argument. We have no metrics, CIs, ablations, architecture details, label horizons, or baseline reimplementation protocol. The load-bearing assumption is exactly the one the reader flagged: that the gains are not artifacts of splits, follow-up windows, preprocessing, or unequal hyperparameter budgets, and that single-view-aligned and multi-view-unaligned SOTA were run under comparable conditions. That cannot be checked from the abstract. Novelty is incremental composition of two already-valued ingredients, not a new principle. Free parameters (architecture, losses, time horizons) are the usual ML ones.\n\nI would not cite this from the abstract alone, and I would not bring an abstract-only piece to reading group. But it deserves a serious referee if the full paper ships fair baselines, ablations that isolate multi-view vs alignment, and calibrated subgroup numbers. Send it to review rather than desk-reject; the claim is important enough within screening ML and the framing is honest. If the methods section is thin or the baselines are soft, the referees will catch it. If the ablations hold, this is a useful systems paper for the mammography risk crowd.","headline":"Abstract-only systems paper: joint multi-view + explicit longitudinal alignment is a sensible gap-fill, but outperformance is unverifiable without methods and numbers.","tokens_in":2869,"tokens_out":509,"would_cite":false,"duration_ms":4282,"reading_group":"no","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.5","headline":"LMV-Net jointly models CC and MLO mammography views with explicit longitudinal alignment to improve breast cancer risk prediction.","keywords":["breast cancer risk prediction","mammography","longitudinal imaging","multi-view","CC MLO","deep learning","EMBED","CSAW-CC"],"falsifier":"A controlled re-run of LMV-Net against the same baselines on EMBED and CSAW-CC under identical splits, follow-up windows, preprocessing, and hyperparameter search budgets that erases or reverses the reported performance gap.","tokens_in":2897,"feed_emoji":"🩺","tokens_out":505,"duration_ms":4111,"temperature":0.7,"pith_summary":"This paper argues that breast cancer risk prediction from screening mammograms improves when a model jointly analyzes the two standard complementary views (craniocaudal and mediolateral oblique) inside an explicitly time-aligned longitudinal framework. Prior deep learning work either aligned exams over time using only one view, or fused multiple views without explicit temporal alignment, so neither captured the full spatial-temporal information radiologists routinely use. LMV-Net closes that gap. On the public EMBED and CSAW-CC datasets it consistently outperforms existing risk models overall and within breast-density and cancer subgroups. If the claim holds, multi-view longitudinal modeling can tighten risk stratification, support personalized screening intervals, and focus resources on higher-risk patients earlier.","feed_headline":"Multi-view longitudinal model beats prior mammogram risk predictors","feed_subtitle":"LMV-Net fuses CC and MLO views with explicit time alignment and lifts accuracy on EMBED and CSAW-CC.","key_machinery":"LMV-Net itself: a network that fuses the two standard mammographic views (CC and MLO) while enforcing explicit temporal alignment of successive exams, so complementary spatial cues and change over time are modeled together rather than separately.","core_discovery":"LMV-Net, by jointly analyzing anatomically complementary CC and MLO views within an explicitly aligned longitudinal framework, consistently outperforms existing state-of-the-art breast cancer risk prediction methods in overall performance and across breast density and cancer subgroups on the public EMBED and CSAW-CC datasets.","pith_inferences":[],"forward_implications":[],"fun_headline_variants":["LMV-Net tops SOTA breast risk models via multi-view longitudinal fusion","Aligned CC-MLO mammograms boost cancer risk prediction on EMBED CSAW","Dual-view time-aligned model beats prior mammogram risk predictors","LMV-Net lifts risk accuracy across density and cancer subgroups","Joint multi-view longitudinal analysis outperforms existing methods"],"cache_read_input_tokens":2304,"weakest_assumption_plain":"The reported gains truly come from the joint multi-view plus explicit longitudinal design and not from differences in evaluation protocol, data splits, label windows, preprocessing, or hyperparameter budgets relative to the reimplemented baselines.","fun_headline_variants_meta":{"raw":{"variants":["LMV-Net tops SOTA breast risk models via multi-view longitudinal fusion","Aligned CC-MLO mammograms boost cancer risk prediction on EMBED CSAW","Dual-view time-aligned model beats prior mammogram risk predictors","LMV-Net lifts risk accuracy across density and cancer subgroups","Joint multi-view longitudinal analysis outperforms existing methods"]},"model":"grok-4.5","effort":"low","cost_usd":0.005112,"raw_usage":{"total_tokens":1408,"prompt_tokens":738,"num_sources_used":0,"completion_tokens":75,"cost_in_usd_ticks":51120000,"prompt_tokens_details":{"text_tokens":738,"audio_tokens":0,"image_tokens":0,"cached_tokens":256},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":595,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":738,"tokens_out":75,"duration_ms":4729,"temperature":1.0,"reasoning_tokens":595,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-07-14T01:46:08.029937+00:00","model_set":{"reader":"grok-4.5"},"falsifier":"A controlled re-run of LMV-Net against the same baselines on EMBED and CSAW-CC under identical splits, follow-up windows, preprocessing, and hyperparameter search budgets that erases or reverses the reported performance gap.","supporting_citations":[],"review_version":1}